Literature DB >> 9637406

High frequency of apolipoprotein E epsilon 2 allele is specific for patients with cerebral amyloid angiopathy-related haemorrhage.

M O McCarron1, J A Nicoll.   

Abstract

The apolipoprotein E (APOE) epsilon 2 allele is a putative risk factor for cerebral amyloid angiopathy-related haemorrhage. We explored the frequency of the APOE epsilon 2 allele in intracranial haemorrhage due to three different pathophysiological mechanisms to determine the specificity of the association. APOE genotypes in 207 autopsies with intracranial haemorrhage (96 subarachnoid haemorrhage, 71 deep intracerebral haemorrhage, 40 cerebral amyloid angiopathy (CAA)-related haemorrhage patients) were compared with 41 autopsy controls without neuropathological abnormalities and 406 living patients admitted to hospital following head injury. As identified previously the epsilon 2 allele frequency was significantly over-represented in CAA-related haemorrhage (frequency 0.24, P < 0.01); this association was stronger among patients with multiple CAA-related haematomas (0.31). The epsilon 2 frequencies of the deep haemorrhage (0.13) and subarachnoid haemorrhage (0.09) groups were not significantly different from the control autopsies (0.07) or live patients (0.08). The findings indicate that the epsilon 2 allele is associated with haemorrhage only in the context of cerebral blood vessels laden with amyloid.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9637406     DOI: 10.1016/s0304-3940(98)00286-9

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  21 in total

1.  Links between the pathology of Alzheimer's disease and vascular dementia.

Authors:  Marcin Sadowski; Joanna Pankiewicz; Henrieta Scholtzova; Yong-sheng Li; David Quartermain; Karen Duff; Thomas Wisniewski
Journal:  Neurochem Res       Date:  2004-06       Impact factor: 3.996

Review 2.  [Zerebrale Amyloidangiopathie : Cerebral amyloid angiopathy].

Authors:  F Block
Journal:  Nervenarzt       Date:  2011-02       Impact factor: 1.214

3.  Apolipoprotein E, statins, and risk of intracerebral hemorrhage.

Authors:  Daniel Woo; Ranjan Deka; Guido J Falcone; Matthew L Flaherty; Mary Haverbusch; Sharyl R Martini; Steven M Greenberg; Alison M Ayres; Laura Sauerbeck; Brett M Kissela; Dawn O Kleindorfer; Charles J Moomaw; Christopher D Anderson; Joseph P Broderick; Jonathan Rosand; Carl D Langefeld; Jessica G Woo
Journal:  Stroke       Date:  2013-09-05       Impact factor: 7.914

4.  Cerebral amyloid angiopathy in traumatic brain injury: association with apolipoprotein E genotype.

Authors:  P D Leclercq; L S Murray; C Smith; D I Graham; J A R Nicoll; S M Gentleman
Journal:  J Neurol Neurosurg Psychiatry       Date:  2005-02       Impact factor: 10.154

Review 5.  [Cerebral amyloid angiopathy associated with inflammation].

Authors:  J Schaumberg; M Trauscheid; B Eckert; D Petersen; W Schulz-Schaeffer; J Röther; W Heide
Journal:  Nervenarzt       Date:  2018-06       Impact factor: 1.214

Review 6.  Cerebral Amyloid Angiopathy in Stroke Medicine.

Authors:  Frank Block; Manuel Dafotakis
Journal:  Dtsch Arztebl Int       Date:  2017-01-20       Impact factor: 5.594

7.  Association between Apolipoprotein E genotype and cerebral palsy is not confirmed in a Caucasian population.

Authors:  Gai L McMichael; Catherine S Gibson; Paul N Goldwater; Eric A Haan; Kevin Priest; Gustaaf A Dekker; Alastair H MacLennan
Journal:  Hum Genet       Date:  2008-09-23       Impact factor: 4.132

Review 8.  The role of APOE in cerebrovascular dysfunction.

Authors:  Leon M Tai; Riya Thomas; Felecia M Marottoli; Kevin P Koster; Takahisa Kanekiyo; Alan W J Morris; Guojun Bu
Journal:  Acta Neuropathol       Date:  2016-02-16       Impact factor: 17.088

Review 9.  Clinical diagnosis of cerebral amyloid angiopathy: validation of the Boston criteria.

Authors:  Eric E Smith; Steven M Greenberg
Journal:  Curr Atheroscler Rep       Date:  2003-07       Impact factor: 5.113

Review 10.  Resumption of Anticoagulation After Intracranial Hemorrhage.

Authors:  Ivan Rocha Ferreira da Silva; Jennifer A Frontera
Journal:  Curr Treat Options Neurol       Date:  2017-09-30       Impact factor: 3.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.